{
    "nctId": "NCT04059809",
    "briefTitle": "Photobiomodulation for Breast Cancer Radiodermatitis",
    "officialTitle": "Photobiomodulation for Breast Cancer Radiodermatitis Prevention. A Randomized Controlled Trial.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Radiodermatitis, Radiotherapy Side Effect, Radiation Dermatitis, Radiation Toxicity, Radiation Injuries, Quality of Life, Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2, PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 48,
    "primaryOutcomeMeasure": "Grade of Radiodermatitis",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer\n* Mastectomy or breast conserving surgery\n* Informed consent\n* Radiotherapy schedule completion\n\nExclusion Criteria:\n\n* Auto-immune disorders\n* Immediate reconstruction",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}